Down syndrome and thyroid dysfunction: should nutritional support be the first-line treatment?
Individuals with Down syndrome (DS) not only have increased risk of hypothyroidism, they also tend to develop a relatively novel mild form of neonatal hypothyroidism. One problem that may predispose those with trisomy 21 to hypothyroidism is the overexpression of the gene DYRK1A, which may have an affect on the thyroid. While thyroxine supplementation (such as Synthroid) is increasingly being advised for those with DS, this treatment may have both positive and negative effects. Nutritional support for hypothyroidism offers some of the same benefits as drug therapy but without the likely negative long-term effects. Early 20th century practitioners used bovine glandulars for those with DS children, which were believed to help support thyroid function. Some doctors in more recent times have also included iodine, L-tyrosine, selenium, and zinc. As nutrition for those with DS has been safely used by some practitioners for many decades, it is suggested that nutritional thyroid support, and not necessarily thyroxine, should be considered for use as a first line treatment for those with trisomy 21. This paper also hypothesizes that nutritional interventions begun prenatally by the mother, may possibly also be of benefit.
Thiel
R
R
Center for Natural Health Research, Down Syndrome-Epilepsy Foundation, 1248 E. Grand Avenue, Suite A, Arroyo Grande, CA 93420, USA. drthiel@aol.com
Fowkes
Steven Wm
SW
D004314:Down Syndrome / Q000503:physiopathology* / Q000628:therapy*; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000503:physiopathology* / Q000517:prevention & control; D008297:Male; D008954:Models, Biological; D018529:Nutritional Support; D012643:Selenium / Q000627:therapeutic use; D013961:Thyroid Gland / Q000503:physiopathology; D014443:Tyrosine / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use
D014443:Tyrosine; D012643:Selenium; D015032:Zinc